Found 9 results
Author Title Type [ Year(Asc)]
Filters: Author is Ling, W  [Clear All Filters]
2016
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., Korthuis, P., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., Buprenorphine + Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study, Addiction, vol. 111, no. 6, pp. 1416-1427, 2016.
J. D. Lee, Nunes, E. V., Novo, P., Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study Design and Rationale, Contemp Clin Trials, 2016.
A. G. Matthews, Hillhouse, M. P., Thomas, C., Ling, W., and Blumberg, D., Participant Treatment Assignment Perceptions in the NIDA CTN Cocaine Use Reduction with Buprenorphine Study, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
R. Lindblad, Saxon, A., Van Veldhuisen, P., Lu, L., Hu, L., Hasson, A., Thomas, C., Sparenborg, S., Mooney, L., and Ling, W., Safety of Combination Buprenorphine/Naloxone and Extended Release Naltrexone, in 2016 CPDD Scientific Meeting, Palm Springs, CA, 2016.
L. J. Mooney, Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., and Ling, W., Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder, J Addict Med, vol. 10, no. 4, pp. 236-243, 2016.